Helicobacter pylori activates calpain via toll-Like receptor 2 to disrupt adherens junctions in human gastric epithelial cells

Infection and Immunity

Volumn 79, Issue 10, 2011, Pages 3887-3894

  O'Connor, Pamela M ^a   Lapointe, Tamia K ^a   Jackson, Shannon ^b   Beck, Paul L ^c   Jones, Nicola L ^d   Buret, Andre G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CAGA PROTEIN; CALPAIN; TOLL LIKE RECEPTOR 2; UVOMORULIN; VIRULENCE FACTOR;

ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL VIRULENCE; CELL JUNCTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; STOMACH EPITHELIUM;

ADHERENS JUNCTIONS; BETA CATENIN; CADHERINS; CALPAIN; CELL LINE; CELL LINE, TUMOR; ENZYME ACTIVATION; EPITHELIAL CELLS; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; TOLL-LIKE RECEPTOR 2;

EID: 80855127793     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05109-11     Document Type: Article

References (52)

1. Bebb, J. R., et al. 2006. Effects of Helicobacter pylori on the cadherin-catenin complex. J. Clin. Pathol. 59:1261-1266.
2. Blaser, M. J., et al. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.
3. Buret, A., and Y. C. Lin. 2008. Genotypic characterization of an epithelial cell line for the study of parasite-epithelial interactions. J. Parasitol. 94:545-548.
4. Chan, A. O., et al. 2001. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut 48:808-811.
5. Chin, A. C., et al. 2002. Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase-3-dependent manner. Infect. Immun. 70:3673-3680.
6. Christofori, G., and H. Semb. 1999. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci. 24:73-76.
7. 2+-dependent signaling by TLR2. J. Immunol. 177:1330-1337.
8. Chun, J., and A. Prince. 2009. TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. Cell Host Microbe 5:47-58.
9. Conacci-Sorrell, M., J. Zhurinsky, and A. Ben-Ze'ev. 2002. The cadherincatenin adhesion system in signaling and cancer. J. Clin. Invest. 109:987-991.
10. Conlin, V. S., et al. 2004. Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells. Infect. Immun. 72:5181-5192.
11. Davies, G., W. G. Jiang, and M. D. Mason. 2001. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin. Cancer Res. 7:3289-3297.
12. Fedwick, J. P., T. K. Lapointe, J. B. Meddings, P. M. Sherman, and A. G. Buret. 2005. Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability. Infect. Immun. 73:7844-7852.
13. Fettucciari, K., et al. 2006. Group B streptococcus induces macrophage apoptosis by calpain activation. J. Immunol. 176:7542-7556.
14. Franco, A. T., et al. 2005. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 102:10646-10651.
15. Franco, A. T., et al. 2008. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 68:379-387.
16. Franco, S. J., and A. Huttenlocher. 2005. Regulating cell migration: calpains make the cut. J. Cell Sci. 118:3829-3838.
17. Goll, D. E., V. F. Thompson, H. Li, W. Wei, and J. Cong. 2003. The calpain system. Physiol. Rev. 83:731-801.
18. Guilford, P., et al. 1998. E-cadherin germline mutations in familial gastric cancer. Nature 392:402-405.
19. Huang, J. Q., S. Sridhar, Y. Chen, and R. H. Hunt. 1998. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114:1169-1179.
20. Katayama, M., et al. 1994. Soluble E-cadherin fragments increased in circulation of cancer patients. Br. J. Cancer 69:580-585.
21. Kwok, T., et al. 2007. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449:862-866.
22. Lee, K. H., et al. 2007. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells. Eur. Surg. Res. 39:208-215.
23. Liu, L., D. Xing, and W. R. Chen. 2009. Micro-calpain regulates caspasedependent and apoptosis inducing factor-mediated caspase-independent apoptotic pathways in cisplatin-induced apoptosis. Int. J. Cancer 125:2757-2766.
24. Marshall, B. J., et al. 1988. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet ii:1437-1442.
25. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1315.
26. McCaig, C., et al. 2006. The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori. Gastroenterology 130:1754-1763.
27. Miehlke, S., et al. 2000. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer 87:322-327.
28. Miehlke, S., et al. 2001. Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease. Am. J. Gastroenterol. 96:1008-1013.
29. Murata-Kamiya, N., et al. 2007. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26:4617-4626.
30. Nagafuchi, A. 2001. Molecular architecture of adherens junctions. Curr. Opin. Cell Biol. 13:600-603.
31. Noe, V., et al. 2001. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J. Cell Sci. 114:111-118.
32. Parsonnet, J., G. D. Friedman, N. Orentreich, and H. Vogelman. 1997. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297-301.
33. Rios-Doria, J., et al. 2003. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J. Biol. Chem. 278:1372-1379.
34. Rios-Doria, J., R. Kuefer, S. P. Ethier, and M. L. Day. 2004. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Cancer Res. 64:7237-7240.
35. Schirrmeister, W., et al. 2009. Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection. Exp. Cell Res. 315:3500-3508.
36. Smith, M. F., Jr., et al. 2003. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem. 278:32552-32560.
37. Tan, Y., C. Wu, T. De Veyra, and P. A. Greer. 2006. Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J. Biol. Chem. 281:17689-17698.
38. Tolwinski, N. S., and E. Wieschaus. 2004. Rethinking WNT signaling. Trends Genet. 20:177-181.
39. Tomb, J. F., et al. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547.
40. Tsukashita, S., et al. 2003. Beta-catenin expression in intramucosal neoplastic lesions of the stomach. Comparative analysis of adenoma/dysplasia, adenocarcinoma and signet-ring cell carcinoma. Oncology 64:251-258.
41. Turner, J. R. 2009. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9:799-809.
42. Ulger Toprak, N., et al. 2006. The distribution of the bft alleles among enterotoxigenic Bacteroides fragilis strains from stool specimens and extraintestinal sites. Anaerobe 12:71-74.
43. Uno, K., et al. 2007. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 293:G1004-G1012.
44. Wang, C., Y. Yuan, and R. H. Hunt. 2007. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am. J. Gastroenterol. 102:1789-1798.
45. Weydig, C., A. Starzinski-Powitz, G. Carra, J. Lower, and S. Wessler. 2007. CagA-independent disruption of adherence junction complexes involves Ecadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity. Exp. Cell Res. 313:3459-3471.
46. Wiemer, A. J., M. A. Lokuta, J. C. Surfus, S. A. Wernimont, and A. Huttenlocher. 2010. Calpain inhibition impairs TNF-alpha-mediated neutrophil adhesion, arrest and oxidative burst. Mol. Immunol. 47:894-902.
47. Wroblewski, L. E., et al. 2003. Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration. J. Cell Sci. 116:3017-3026.
48. Wu, S., K. C. Lim, J. Huang, R. F. Saidi, and C. L. Sears. 1998. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. U. S. A. 95:14979-14984.
49. Wu, S., K. J. Rhee, M. Zhang, A. Franco, and C. L. Sears. 2007. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. J. Cell Sci. 120:1944-1952.
50. Yamaoka, Y., et al. 2002. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 123:414-424.
51. Yamaoka, Y., et al. 2002. Helicobacter pylori infection in mice: role of outer membrane proteins in colonization and inflammation. Gastroenterology 123:1992-2004.
52. Yokota, S., T. Okabayashi, M. Rehli, N. Fujii, and K. Amano. 2010. Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogenactivated protein kinase pathway. Infect. Immun. 78:468-476.